— Know what they know.
Not Investment Advice

NBY

NovaBay Pharmaceuticals, Inc.
1W: +12.5% 1M: -12.7% 3M: -73.5% YTD: -95.1% 1Y: +251.4% 3Y: -95.6% 5Y: -99.8%
$1.51
+0.10 (+6.69%)
After Hours: $1.53 (+0.02, +0.99%)
AMEX · Healthcare · Biotechnology · $37.1M · Alpha Radar Sell · Power 30
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$37.1M
52W Range1.11-99.75
Volume377,271
Avg Volume509,974
Beta0.20
Dividend$0.80
Analyst Ratings
2 Buy 3 Hold 0 Sell
Consensus Hold
Company Info
CEOMichael Kazley
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2007-10-26
2000 Powell Street
EmeryVille, CA 94608
US
510 899 8800
About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Recent Insider Trades

NameTypeSharesPriceDate
Lazar David E. A-Award 6,388,000 2025-10-21
Lazar David E. M-Exempt 39,925 2025-10-21
Framework Ventures I C-Conversion 56,806,080 2025-10-21
R01 Fund LP C-Conversion 56,806,080 2025-10-21
Kazley Michael John C-Conversion 56,806,080 2025-10-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms